CSS
WINT

Cubist Systematic Strategies’s Windtree Therapeutics WINT Stock Holding History

Cubist Systematic Strategies’s Portfolio WINT Stock Details WINT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-274
Closed -$4.78K – 3606
2024
Q4 		$4.78K Buy
+274
New +$8.7K ﹤0.01% 2879

Other funds holding WINT

UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

Cubist Systematic Strategies's WINT Position: Q1 2025 in Review

Cubist Systematic Strategies sold out of Windtree Therapeutics (WINT) in Q1 2025, closing a stake of 274 shares — an estimated $4.78K sold.

Cubist Systematic Strategies first reported a position in WINT in Q4 2024 and held it in 1 quarter. The position peaked at $4.78K in Q4 2024. 5 funds tracked by Wall St. Rank hold WINT as of Q1 2025.

  • Cubist Systematic Strategies reported no remaining Windtree Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Cubist Systematic Strategies sold 274 Windtree Therapeutics shares in Q1 2025, an estimated $4.78K.
  • Cubist Systematic Strategies first reported a position in Windtree Therapeutics in Q4 2024 and held it in 1 quarter.
  • Cubist Systematic Strategies's Windtree Therapeutics position peaked at $4.78K in Q4 2024.
  • 5 funds tracked by Wall St. Rank held Windtree Therapeutics as of Q1 2025.

Based on Cubist Systematic Strategies's 13F filing for Q1 2025, filed 15 May 2025.